United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read General business news Pluribus Technologies completes asset sale of TeleMED and TDM Pluribus Technologies Corp. (TSXV: PLRB), a notable player in the technology sector, has officially concluded the sale of… byPallavi MadhirajuMay 11, 2024